Implantable devices now being tested were developed in Australia and could improve the quality of patients’ lives. These novel devices were presented to the congress of BRAINN.
Studies conducted at BRAINN and part of international consortia are able to identify better treatments for diseases such as epilepsy, cerebral vascular accident and amyotrophic lateral sclerosis.
Study suggests dysregulation of gene NEUROG2 could be linked to development of focal cortical dysplasia, one of the most common causes of drug-resistant epilepsy
A multicenter study involving BRAINN, a research center funded by FAPESP, analyzed the brains of over 3,800 volunteers in search of anatomical alterations specific to each epilepsy subtype
Researchers endeavoring to identify genetic markers for amyotrophic lateral sclerosis verify the importance of analyzing the spinal cord more carefully in cases of the disease
Projects presented during the 4th BRAINN Congress in Brazil combine physical rehab treatments with technology. Fun and electronic games can make sessions more stimulating and effective for patients with motor limitations
Methodology is being developed by multinational Seven Bridges in collaboration with BIPMed
In vitro study by Brazilian researcher affiliated with George Mason University was presented to 4th BRAINN Congress at the University of Campinas in São Paulo State